Key result
Elevated cardiac troponin I in patients with SIRS or sepsis was not associated with significant differences in ex vivo coagulation parameters compared to troponin-negative patients.
Why the study?
Are coagulation disturbances associated with elevated cardiac troponin I in patients with sepsis and septic shock?
Observational (n=38)
No
Are coagulation disturbances associated with elevated cardiac troponin I in patients with sepsis and septic shock?
Elevated cardiac troponin I in sepsis and septic shock is not associated with coagulation disturbances measured by ROTEM, suggesting mechanisms other than thrombus-associated myocardial necrosis.
Answers are grounded in this paper and cite their sources.
May support non-thrombotic troponin release in sepsis; hypothesis-generating and should not yet change practice.
BACKGROUND: Elevated cardiac troponin I (cTnI) is frequently observed in patients with severe sepsis and septic shock. However, the mechanisms underlying cTnI release in these patients are still unknown. To date no data regarding coagulation disturbances as a possible mechanism for cTnI release during sepsis are available. METHODOLOGY/PRINCIPAL FINDINGS: Consecutive patients with systemic inflammatory response syndrome (SIRS), sepsis or septic shock without evidence of an acute coronary syndrome were analyzed. Coagulation parameters (clotting time (CT), clot formation time (CFT), maximum clot firmness (MCF), alpha-angle) were assessed in native whole blood samples, and using specific activators to evaluate the extrinsic and intrinsic as well as the fibrin component of the coagulation pathway with the use of rotational thrombelastometry (ROTEM). Thirty-eight patients were included and 22 (58%) were cTnI-positive. Baseline characteristics between TnI-positive and -negative patients were similar. The CT, CFT, MCF and the alpha-angle were similar between the groups with trends towards shorter CT in the extrinsic and fibrin activation. CONCLUSIONS/SIGNIFICANCE: We found no differences in coagulation parameters analyzed with rotational thrombelastometry between cTnI-positive and -negative patients with SIRS, severe sepsis, and septic shock. These findings suggest that pathophysiological mechanisms other than thrombus-associated myocardial damage might play a major role, including reversible myocardial membrane leakage and/or cytokine mediated apoptosis in these patients.
No takes yet. Share an insight, caveat, or question.
Altmann et al. (2010) conducted an observational in Systemic inflammatory response syndrome (SIRS), severe sepsis, and septic shock (n=38). Elevated cardiac troponin I (cTnI-positive) vs. cTnI-negative was evaluated on Native clotting time (NATEM CT) in seconds (p=0.50). Elevated cardiac troponin I in patients with SIRS or sepsis was not associated with significant differences in ex vivo coagulation parameters compared to troponin-negative patients.
Synapse has enriched 10 related papers. Consider them for comparative context: